DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI

NCT07162506 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

PROCEDURE: Surgery
RADIATION: Radiotherapy
DRUG: Chemotherapy
DRUG: Immunotherapy

Sponsor

Tianjin Medical University Cancer Institute and Hospital

Collaborators

[object Object]
[object Object]
[object Object]